Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Remedies Ltd - 540937 - Reg. 34 (1) Annual Report

 Dear Sir/Madam, Pursuant to the provisions of Regulation 34 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Annual Report for the Financial Year 2019-20 along with Notice of 26th Annual General Meeting. The Annual Report for the Financial Year 2019-20 is uploaded on the website of the Company http://medicoremedies.com/ Kindly take the same on records.
04-09-2020
Bigul

Medico Remedies Ltd - 540937 - Outcome Of The Board Meeting Held Today

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that at the Meeting of Board of Directors of our Company held today i.e. 24th August, 2020 has, inter alia considered and approved the following: 1. The 26th Annual General Meeting (AGM) of the Company shall be convened on September 30, 2020 at 11.00 a.m. at 1105/1106, 11th Floor, Hubtown Solaris, Opp. Telli Galli, N S Phadke Marg, Andheri East, Mumbai - 400069 2. Re-appointment of Mr. Haresh Mehta (DIN : 01080289) as Chairman & Whole-Time Director on the Board of the Company. 3. Re-appointment of Mr. Rishit Mehta (DIN : 07121224) as Whole-Time Director on the Board of the Company. 4. Revision in terms of remuneration of Mr. Harshit Mehta (DIN : 05144280, Managing Director of the Company
24-08-2020
Bigul

Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended June 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Haresh MehtaDesignation :- Managing Director / Whole Time Director
10-07-2020
Bigul

Medico Remedies Ltd - 540937 - Outcome Of The Board Meeting Held Today

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that at the Meeting of Board of Directors of our Company held today i.e. 27th June, 2020 has, inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the half year ended 31st March, 2020 and Audited Financial Statement for the year ended on 31st March, 2020 along with the Auditor's Report thereon. We wish to inform you that the Board Meeting commenced today at 4.00 P.M and concluded at 4.30 P.M Kindly take the same on record and oblige
27-06-2020
Bigul

Medico Remedies Ltd - 540937 - Outcome Of The Board Meeting Held Today

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that at the Meeting of Board of Directors of our Company held today i.e. 27th June, 2020 has, inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the half year ended 31st March, 2020 and Audited Financial Statement for the year ended on 31st March, 2020 along with the Auditor's Report thereon. We wish to inform you that the Board Meeting commenced today at 4.00 P.M and concluded at 4.30 P.M Kindly take the same on record and oblige
27-06-2020
Bigul

Medico Remedies Ltd - 540937 - Submission Of Disclosure Of Impact Of COVID-19 Pandemic On The Company Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

 Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020 please find enclosed herewith disclosure on material impact of COVID - 19 pandemic on the Company. You are requested to kindly take the same on record and acknowledge the receipt Thanking you,
24-06-2020
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Intimation for Notice Of The Board Meeting

 Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/06/2020 ,inter alia, to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on 27th June, 2020, inter alia, to transact the following business: 1. To consider and approve, the Audited Financial Results for the half year ended 31st March, 2020 and Audited Financial Statement for the year ended on 31st March, 2020 as recommended by the Audit Committee and take note of Auditor''s Report thereon; and 2. Any other business with the permission of the Chair Kindly take the same on record.
20-06-2020
Bigul

Medico Remedies Ltd - 540937 - Compliance Certificate For The Half Year Ended On 31/03/2020 Pursuant To Regulation 7(3) Of The SEBI (LODR) Regulations, 2015

 We hereby submit the duly signed Compliance Certificate for the year ended on 31-03-2020 pursuant to Regulation 7(3) of the SEBI (LODR) Regulations, 2015. You are requested to kindly take the same on record and acknowledge the receipt. Thanking you, Yours faithfully,
17-04-2020
Bigul

Medico Remedies Ltd - 540937 - Certificate U/R 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2020

 We hereby submit Certificate issued by Practising Company Secretary u/r 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Year ended on 31st March, 2020. You are requested to kindly take the same on record and acknowledge the receipt. Thanking you, Yours faithfully,
17-04-2020
Bigul

Medico Remedies Ltd - 540937 - Shareholding for the Period Ended March 31, 2020

 Medico Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
17-04-2020
Next Page
Close

Let's Open Free Demat Account